0001493152-24-005749.txt : 20240209 0001493152-24-005749.hdr.sgml : 20240209 20240209171047 ACCESSION NUMBER: 0001493152-24-005749 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 EFFECTIVENESS DATE: 20240209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RetinalGenix Technologies Inc. CENTRAL INDEX KEY: 0001836295 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 823936890 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-504938 FILM NUMBER: 24616093 BUSINESS ADDRESS: STREET 1: 1450 NORTH MCDOWELL BOULEVARD STREET 2: SUITE 150 CITY: PETALUMA STATE: CA ZIP: 94954 BUSINESS PHONE: 415-578-9583 MAIL ADDRESS: STREET 1: 1450 NORTH MCDOWELL BOULEVARD STREET 2: SUITE 150 CITY: PETALUMA STATE: CA ZIP: 94954 D 1 primary_doc.xml X0708 D LIVE 0001836295 RetinalGenix Technologies Inc. 1450 NORTH MCDOWELL BOULEVARD SUITE 150 PETALUMA CA CALIFORNIA 94954 (415)578-9583 DELAWARE None None Corporation true Jerry Katzman c/o RetinalGenix Technologies Inc. 1450 North McDowell Boulevard Suite 150 Petaluma CA CALIFORNIA 94954 Executive Officer Director Chief Executive Officer Herbert Gould c/o RetinalGenix Technologies Inc. 1450 North McDowell Boulevard Suite 150 Petaluma CA CALIFORNIA 94954 Director Vinay Mehindru c/o RetinalGenix Technologies Inc. 1450 North McDowell Boulevard Suite 150 Petaluma CA CALIFORNIA 94954 Director Virender Ahluwalia c/o RetinalGenix Technologies Inc. 1450 North McDowell Boulevard Suite 150 Petaluma CA CALIFORNIA 94954 Executive Officer Interim Chief Financial Officer Biotechnology Decline to Disclose 06b false 2024-01-23 false true true true false 0 None None None None NONE NONE XX Unknown 000 AZ ARIZONA CA CALIFORNIA CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS MA MASSACHUSETTS MN MINNESOTA NE NEBRASKA NV NEVADA NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA SC SOUTH CAROLINA TN TENNESSEE TX TEXAS true 4650000 4650000 0 false 17 0 0 0 While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers. false RetinalGenix Technologies Inc. /s/ Jerry Katzman Jerry Katzman Chief Executive Officer and Chairman 2024-02-09